THE EFFECT OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: QUASAR PHASE 2B INDUCTION RESULTS AT WEEK 12 BY PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO ADVANCED THERAPY

Julian Panés  ¹     Jessica Allegretti  ²     Bruce E. Sands  ³     Kuan-Hsiang G. Huang  ⁴     Mary Kavalam  ⁴     Matthew Germinaro  ⁴     Rebbecca Wilson  ⁴     Hongyan Zhang  ⁴     Emese Mihály  ⁵     Tadakazu Hisamatsu  ⁶     Axel Dignass  ⁷     David T. Rubin  ^8    
1 Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
² Brigham and Women´s Hospital, Boston, United States
³ Icahn School of Medicine at Mount Sinai, New York, United States
⁴ Janssen Research & Development, LLC, Spring House
⁵ Semmelweis University, Budapest, Hungary
⁶ Kyorin University, Tokyo, Japan
⁷ Agaplesion Markus Krankenhaus, Frankfurt/ Main, Germany
⁸ University of Chicago Medicine, Chicago, United States

Topic
IBD, Nurses

Session
Treatment strategies in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)